started · updated
Brazil advances HIV prevention and reports 13 remission cases at AIDS conference
Scientists announced two additional HIV remission cases at the 26th International AIDS Conference in Rio de Janeiro, raising the worldwide total to 13. The patients – one from Kansas City, USA, and another from Essen, Germany – received hematopoietic stem‑cell transplants from donors carrying the CCR5‑delta32 mutation, which blocks HIV entry. After stopping antiretroviral therapy, the Kansas City patient has remained virus‑free for 14 months and the Essen patient for 12 months, though the latter experienced a hepatitis B recurrence.
Brazil's Ministry of Health also signed several agreements on new HIV‑prevention drugs. A memorandum of understanding between Fundação Oswaldo Cruz (Fiocruz) and MSD will enable production of the oral PrEP candidate Alimatravir (MK‑8527), pending phase‑3 trial results and ANVISA approval. The ministry announced a deal with ViiV Healthcare for the injectable PrEP cabotegravir, which will be evaluated by Conitec for possible inclusion in the SUS by the end of the year. Negotiations for the six‑month injectable lenacapavir failed because the price offered by Gilead was deemed unaffordable, even though Brazil was prepared to pay up to ten times the price offered to similar‑income countries.
In a separate initiative, the AIDS Healthcare Foundation and the Pan‑American Health Organization (OPS) signed a collaboration to expand HIV testing and early treatment access across Latin America and the Caribbean.
Entities
Alexandre Padilha · Alimatravir (MK‑8527) · Brazil Ministry of Health · Brazil Ministry of Health (Alexandre Padilha) · Brazilian Ministry of Health · Cabotegravir · Fiocruz (Fundação Oswaldo Cruz) · Fundação Oswaldo Cruz (Fiocruz) · GSK · Kansas City patient · MSD (Merck Sharp & Dohme) · SUS
Claims
What the coverage asserts, and how many sources carry each claim.
- [● 4 SOURCES] Fiocruz signed a memorandum of understanding with MSD to develop Alimatravir (MK‑8527), an oral PrEP still in phase‑3 trials and pending ANVISA approval. esportenaredemt.com.br · folhacentrosul.com.br · noticiasdefranca.com.br
- [● 2 SOURCES] GSK’s proposed price for cabotegravir was described by the Health Minister as “adequate”. anoticiaregional.com.br · expresso360.com.br
- [● 3 SOURCES] Remission is linked to hematopoietic stem‑cell transplants using donors with the CCR5‑delta32 mutation that blocks HIV entry. blink102.com.br · fatopaulista.com.br
- [○ 1 SOURCE] A Fiocruz trial of lenacapavir with 668 volunteers showed efficacy close to 100 % and adherence around 96 %. www.brasilemfolhas.com.br
- [● 3 SOURCES] The Ministry of Health has asked Conitec to incorporate the injectable PrEP cabotegravir into the SUS system by the end of the year. anoticiaregional.com.br · ejornais.com.br · expresso360.com.br
- [● 3 SOURCES] Negotiations for the six‑month injectable lenacapavir failed because Gilead would not accept Brazil’s offer, even though Brazil was prepared to pay up to ten times the price offered to similar‑income‑ anoticiaregional.com.br · diariopernambucano.com.br · ebookcult.com.br
- [● 3 SOURCES] Both patients stopped antiretroviral therapy and have remained with undetectable viral loads for 12 and 14 months. blink102.com.br · fatopaulista.com.br
- [● 3 SOURCES] Two additional HIV remission cases were presented at the 26th International AIDS Conference, raising the worldwide total to 13. blink102.com.br · fatopaulista.com.br
- [○ 1 SOURCE] Activists at the AIDS conference protested the high price of lenacapavir, an injectable HIV‑prevention drug sold for about $28,000 per patient in the United States, demanding broader access to gener‑ www.excelsior.com.mx
- [○ 1 SOURCE] Brazil’s Ministry of Health is evaluating the inclusion of a long‑acting injectable PrEP, administered every two months, into the public health system, with a decision expected in August 2024. carajasojornal.com.br
- [● 5 SOURCES] Two additional patients achieved HIV remission after hematopoietic stem‑cell transplants, raising the total of such cases to 13. www.brasilemfolhas.com.br · primeirojornal.com.br · portalrbn.com.br · tribunadaserra.com.br · vejadetudo.com.br
- [○ 1 SOURCE] Late‑stage HIV diagnoses accounted for about 34% of new infections in Latin America in 2025, and the region recorded roughly 32,000 AIDS‑related deaths that year. www.diariomarca.com.mx